• Keen Vision entered a binding letter of intent with Medera Inc. and Medera unit Novoheart Group to negotiate a replacement merger agreement.
• The letter of intent replaced a prior merger agreement dated Sept. 3, 2024, which was terminated under a mutual release.
• Deadline to sign replacement merger agreement was extended to April 30, 2026 from April 10, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Keen Vision Acquisition Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-043759), on April 15, 2026, and is solely responsible for the information contained therein.